J Am Pharm Assoc (2003). 2020 May-Jun;60(3S):S70-S75. doi: 10.1016/j.japh.2020.03.003. Epub 2020 Apr 3.
To determine if a difference in the use of point-of-care (POC) testing and treatment under a collaborative pharmacy practice agreement exists between insured and uninsured patients and also between patients established with a primary care provider (PCP) and those who are not established. A secondary objective was to assess patient satisfaction with a new, pharmacist-provided service.
Two independent community pharmacies.
Perkins Drugs is an independent community pharmacy practice that operates 2 sites in Gallatin, Tennessee.
This practice innovation was pharmacist-provided POC influenza and group A Streptococcus (GAS) pharyngitis testing and associated treatment when appropriate. Pharmacists entered into a collaborative pharmacy practice agreement with a physician at a nearby primary care clinic, which allowed for the testing and prescribing of medication under a predetermined decision tree.
Patient demographics and satisfaction levels with the service were collected. The service, while continuing, was implemented in December 2018, and cumulative data were collected until April 2019.
Pharmacists tested a total of 73 patients for influenza or GAS. Of the total, 24 patients (33%) did not have an established PCP, and 31 (42.5%) were uninsured. No significant difference was found in the use of the service when comparing the insured and uninsured groups, and participants were more likely to have an established PCP than not have. Of the patients who were contacted for follow-up, 98% reported satisfaction with the delivery of the service stating they would use it again.
Community pharmacy-based POC testing provides access to urgent care services for patients regardless of insurance status. In our experience, the service was well liked by patients and provided a nondispensing source of revenue. This service could potentially be duplicated, as state-based pharmacist scope of practice allows, to provide both a needed service to patients and elevate the pharmacist's role within the health care system.
确定在合作药房实践协议下，保险患者和非保险患者之间以及有初级保健提供者（PCP）和无 PCP 的患者之间是否存在即时检测（POC）和治疗的使用差异。次要目标是评估患者对新的、由药剂师提供的服务的满意度。
两家独立的社区药房。
Perkins Drugs 是一家独立的社区药房，在田纳西州的 Gallatin 经营 2 个地点。
这项实践创新是由药剂师提供即时流感和 A 组链球菌（GAS）咽炎检测，并在适当情况下提供相关治疗。药剂师与附近初级保健诊所的医生签订了合作药房实践协议，根据预定的决策树允许进行检测和开处方药物。
收集了患者的人口统计学和对服务的满意度数据。该服务于 2018 年 12 月继续实施，并在 2019 年 4 月之前收集累计数据。
药剂师总共对 73 名患者进行了流感或 GAS 检测。在总人数中，24 名（33%）没有固定的 PCP，31 名（42.5%）没有保险。在比较保险和非保险组时，服务的使用没有发现显著差异，并且参与者更有可能有固定的 PCP。在联系进行随访的患者中，98%报告对服务的提供表示满意，并表示会再次使用。
基于社区药房的即时检测为患者提供了获得紧急护理服务的机会，无论其保险状况如何。根据我们的经验，该服务受到患者的欢迎，并提供了一种非配药的收入来源。这种服务可以在州级药剂师的实践范围内复制，为患者提供所需的服务，并提升药剂师在医疗保健系统中的角色。
